Skip to content
Article Rich – Lifestyle
Author:
Novonesis (Novozymes A/S)
Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities
August 10, 2026
Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
May 22, 2026
Novonesis delivered strong start to the year with 7% organic sales growth in Q1
May 5, 2026
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England of Journal of Medicine
April 17, 2026
/C O R R E C T I O N — Boehringer Ingelheim/
April 16, 2026
Novonesis expands global footprint with acquisition of production facility in Southeast Asia
April 8, 2026
Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility
March 16, 2026
Novonesis delivered strong organic sales growth of 7% in 2025
March 4, 2026